Inflammation in multiple sclerosis: the good, the bad, and the complex
- 1 December 2002
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 1 (8) , 499-509
- https://doi.org/10.1016/s1474-4422(02)00223-5
Abstract
No abstract availableKeywords
This publication has 119 references indexed in Scilit:
- The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formationNeurobiology of Aging, 2001
- Myelin phagocytosis and remyelination of macrophage-enriched central nervous system aggregate culturesJournal of Neuroscience Research, 2001
- Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosisPublished by Elsevier ,1999
- Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation?The Journal of Experimental Medicine, 1999
- REGULATION OF IMMUNE RESPONSES BY TGF-βAnnual Review of Immunology, 1998
- Myelin Basic Protein–specific T Helper 2 (Th2) Cells Cause Experimental Autoimmune Encephalomyelitis in Immunodeficient Hosts Rather than Protect Them from the DiseaseThe Journal of Experimental Medicine, 1997
- Late Complications of Immune Deviation Therapy in a Nonhuman PrimateScience, 1996
- Magnetic resonance imaging of antibody-mediated demyelinating experimental allergic encephalomyelitisJournal of Neuroimmunology, 1994
- Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple SclerosisScience, 1993
- Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.The Journal of Experimental Medicine, 1992